Style | Citing Format |
---|---|
MLA | Tavvabikashani N, et al.. "Pharmacodynamic, Pharmacokinetic, Toxicity, and Recent Advances in Eugenol's Potential Benefits Against Natural and Chemical Noxious Agents: A Mechanistic Review." Toxicon, vol. 238, no. , 2024, pp. -. |
APA | Tavvabikashani N, Hasanpour M, Baradaran Rahimi V, Vahdatimashhadian N, Askari VR (2024). Pharmacodynamic, Pharmacokinetic, Toxicity, and Recent Advances in Eugenol's Potential Benefits Against Natural and Chemical Noxious Agents: A Mechanistic Review. Toxicon, 238(), -. |
Chicago | Tavvabikashani N, Hasanpour M, Baradaran Rahimi V, Vahdatimashhadian N, Askari VR. "Pharmacodynamic, Pharmacokinetic, Toxicity, and Recent Advances in Eugenol's Potential Benefits Against Natural and Chemical Noxious Agents: A Mechanistic Review." Toxicon 238, no. (2024): -. |
Harvard | Tavvabikashani N et al. (2024) 'Pharmacodynamic, Pharmacokinetic, Toxicity, and Recent Advances in Eugenol's Potential Benefits Against Natural and Chemical Noxious Agents: A Mechanistic Review', Toxicon, 238(), pp. -. |
Vancouver | Tavvabikashani N, Hasanpour M, Baradaran Rahimi V, Vahdatimashhadian N, Askari VR. Pharmacodynamic, Pharmacokinetic, Toxicity, and Recent Advances in Eugenol's Potential Benefits Against Natural and Chemical Noxious Agents: A Mechanistic Review. Toxicon. 2024;238():-. |
BibTex | @article{ author = {Tavvabikashani N and Hasanpour M and Baradaran Rahimi V and Vahdatimashhadian N and Askari VR}, title = {Pharmacodynamic, Pharmacokinetic, Toxicity, and Recent Advances in Eugenol's Potential Benefits Against Natural and Chemical Noxious Agents: A Mechanistic Review}, journal = {Toxicon}, volume = {238}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Tavvabikashani N AU - Hasanpour M AU - Baradaran Rahimi V AU - Vahdatimashhadian N AU - Askari VR TI - Pharmacodynamic, Pharmacokinetic, Toxicity, and Recent Advances in Eugenol's Potential Benefits Against Natural and Chemical Noxious Agents: A Mechanistic Review JO - Toxicon VL - 238 IS - SP - EP - PY - 2024 ER - |